We are live on
!
Find out more
DCM
Decade Capital Management Portfolio holdings
AUM
$463M
1-Year Est. Return
13.43%
This Fund
S&P 500
This Quarter
Est. Return
-7.18%
1 Year Est. Return
+13.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$463M
AUM Growth
-$364M
(-44%)
Cap. Flow
-$327M
Cap. Flow
% of AUM
-70.63%
Top 10 Holdings %
Top 10 Hldgs %
34.88%
Holding
175
New
39
Increased
34
Reduced
44
Closed
55
Top Buys
| 1 |
Boston Scientific
BSX
|
+$23.6M |
| 2 |
CPHD
Cepheid Inc
CPHD
|
+$11M |
| 3 |
GHDX
Genomic Health, Inc.
GHDX
|
+$10.8M |
| 4 |
Citizens Financial Group
CFG
|
+$10.6M |
| 5 |
Associated Banc-Corp
ASB
|
+$9.92M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
+$30.4M |
| 2 |
SHPG
Shire pic
SHPG
|
+$23.5M |
| 3 |
Halliburton
HAL
|
+$19.1M |
| 4 |
Humana
HUM
|
+$18.7M |
| 5 |
IQVIA
IQV
|
+$18M |
Sector Composition
| 1 | Healthcare | 37.97% |
| 2 | Financials | 30.79% |
| 3 | Real Estate | 12.02% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Materials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Labcorp
LH
$23.2B
| $28.9M | 6.24% |
310,345
+51,431
| +20% | +$5.32M |
|
|
2
Boston Scientific
BSX
$65.4B
| $22.6M | 4.88% |
+1,378,016
| New | +$23.6M |
|
|
AET
3
DELISTED
Aetna Inc
AET
| $18.3M | 3.95% |
167,479
-29,110
| -15% | -$3.36M |
|
4
Edwards Lifesciences
EW
$49.4B
| $17.7M | 3.82% |
747,666
+224,754
| +43% | +$5.42M |
|
|
SEM
5
DELISTED
Select Medical
SEM
| $15.2M | 3.29% |
2,620,782
+370,412
| +16% | +$2.75M |
|
|
HOLX
6
DELISTED
Hologic
HOLX
| $13.6M | 2.94% |
348,705
-184,929
| -35% | -$7.33M |
|
|
NUVA
7
DELISTED
NuVasive, Inc.
NUVA
| $12.7M | 2.75% |
264,212
-226,100
| -46% | -$11.7M |
|
|
FNFG
8
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $11.7M | 2.53% |
1,150,246
+218,419
| +23% | +$2.07M |
|
|
UMPQ
9
DELISTED
Umpqua Holdings Corp
UMPQ
| $10.4M | 2.24% |
636,843
+52,547
| +9% | +$904K |
|
10
KeyCorp
KEY
$25.4B
| $10.3M | 2.22% |
792,285
+497,054
| +168% | +$7.06M |
|
|
11
Citizens Financial Group
CFG
$30.6B
| $9.93M | 2.14% |
+416,146
| New | +$10.6M |
|
|
WBA
12
DELISTED
Walgreens Boots Alliance
WBA
| $9.75M | 2.1% |
117,282
+38,167
| +48% | +$3.45M |
|
|
SHPG
13
DELISTED
Shire pic
SHPG
| $9.68M | 2.09% |
47,148
-98,824
| -68% | -$23.5M |
|
|
SRC
14
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $9.63M | 2.08% |
234,990
+41,594
| +22% | +$1.84M |
|
|
15
Associated Banc-Corp
ASB
$5.92B
| $9.35M | 2.02% |
+520,303
| New | +$9.92M |
|
|
CPHD
16
DELISTED
Cepheid Inc
CPHD
| $9.34M | 2.01% |
+206,520
| New | +$11M |
|
|
GHDX
17
DELISTED
Genomic Health, Inc.
GHDX
| $8.87M | 1.91% |
+419,274
| New | +$10.8M |
|
|
TCF
18
DELISTED
TCF Financial Corporation
TCF
| $8.84M | 1.91% |
583,273
+190,974
| +49% | +$3.04M |
|
|
AF
19
DELISTED
Astoria Financial Corporation
AF
| $8.27M | 1.78% |
513,593
+60,326
| +13% | +$932K |
|
20
Universal Health Services
UHS
$9.15B
| $8.03M | 1.73% |
64,362
-53,218
| -45% | -$7.41M |
|
|
ALR
21
DELISTED
Alere Inc
ALR
| $7.84M | 1.69% |
+162,884
| New | +$8.44M |
|
22
Popular Inc
BPOP
$11.1B
| $7.66M | 1.65% |
253,434
-1,162
| -0.5% | -$34.8K |
|
23
Zoetis
ZTS
$32.1B
| $7.61M | 1.64% |
184,888
-36,441
| -16% | -$1.69M |
|
24
Prosperity Bancshares
PB
$8.81B
| $6.29M | 1.36% |
128,008
+75,915
| +146% | +$4.01M |
|
25
McDonald's
MCD
$190B
| $5.75M | 1.24% |
58,413
+1,613
| +3% | +$157K |
|
Similar funds
CWA
GACM
BACM
BMCMI
F
TCOTO
CCM
LOCB
Decade Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Decade Capital Management held 175 positions worth $463M, down 44% from $828M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Decade Capital Management withdrew a net $327M in Q3 2015, closing 55 positions and reducing 44 holdings. Its most notable exit was Halliburton, an estimated $19.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Financials and Real Estate.
Against the trend, Decade Capital Management opened a new position in Boston Scientific worth $22.6M.
- Decade Capital Management's largest Q3 2015 buy was Boston Scientific: 1,378,016 shares worth $22.6M.
- Decade Capital Management added most to KeyCorp in Q3 2015, an estimated $7.06M increase.
- Decade Capital Management's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $30.4M.
- Decade Capital Management fully exited Halliburton in Q3 2015, selling an estimated $19.1M.
- Decade Capital Management's ten largest holdings make up 35% of its $463M portfolio in Q3 2015.
- Decade Capital Management opened 39 new positions and closed 55 in Q3 2015.
- Decade Capital Management's portfolio value fell 44% quarter-over-quarter to $463M.
Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.